GlassScriptPhysician profile
Jill P Karpel
NPI 1225107592
$4,348.33
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,408 · 2020: $2,940.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim International Gmbh | $2,654.61 | 2020 | |
| Glaxosmithkline, LLC. | $501.08 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $187.57 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $152.30 | 2019 | |
| Genentech USA, INC. | $149.73 | 2019-2020 | |
| Grifols USA, LLC | $98.36 | 2019-2020 | |
| Philips North America LLC | $96.49 | 2019-2020 | |
| Mylan Specialty L.P. | $78.32 | 2019-2020 | |
| Electromed, INC. | $65.01 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $60.35 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $50.08 | 2019-2020 | |
| Circassia INC. | $38.72 | 2019 | |
| Sunovion Pharmaceuticals INC. | $37.76 | 2019 | |
| Advanced Respiratory, INC | $35.62 | 2019-2020 | |
| Sanofi Pasteur INC. | $35.19 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $33.94 | 2019-2020 | |
| Shire North American Group INC | $30.29 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.02 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $15.59 | 2019 | |
| Pfizer INC. | $11.30 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jill Karpel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.